Cargando…
The role of (123)I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies
The diagnosis of dementia with Lewy bodies (DLB) is difficult if one relies solely on clinical features. Current International Consensus Criteria for DLB have high specificity but a significant percentage of patients might be misdiagnosed. Reasons for clinical uncertainty regard the presence of conc...
Autor principal: | Antonini, Angelo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654798/ https://www.ncbi.nlm.nih.gov/pubmed/19300562 |
Ejemplares similares
-
Bipolar Disorder and Parkinson's Disease: A (123)I-Ioflupane Dopamine Transporter SPECT Study
por: Erro, Roberto, et al.
Publicado: (2021) -
Patient Survey on Satisfaction and Impact of 123I-Ioflupane Dopamine Transporter Imaging
por: Covington, Matthew F., et al.
Publicado: (2015) -
Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2013) -
CT-Based Attenuation Correction in I-123-Ioflupane SPECT
por: Lange, Catharina, et al.
Publicado: (2014) -
Interpreting (123)I–ioflupane dopamine transporter scans using hybrid scores
por: Nichols, Kenneth J., et al.
Publicado: (2018)